Cambridge, United Kingdom – 12 May 2022 - Congenica, a digital health company that enables precision medicine through its world-leading diagnostic decision support platform for genomic data, has won the award for Technology Company of the Year at the 2022 Cambridge Independent Science and Technology Awards.
The awards recognize and celebrate outstanding achievements of science and technology companies that are based in and around Cambridge UK.
The Technology Company of the Year prize has been awarded to Congenica for its cutting-edge genomic platform, which enables the rapid analysis and interpretation of DNA sequencing data. Congenica’s platform empowers clinicians to provide definitive molecular diagnoses more accurately and rapidly, thereby significantly reducing the “diagnostic odyssey” of rare disease patients from many years to just days.
Andy Richards, Executive Chairman, Congenica, said: "We are honoured to have been recognised within this strong cohort of technology businesses, which are amongst the most innovative in Cambridge and across the world. At Congenica, we are focused on delivering a future where clinical genomics is fully integrated in healthcare to transform the lives of patients, providing fast and accurate diagnoses to enable life-changing answers. [This award/ these awards] recognises the value of Congenica’s technology as we work to achieve this goal.”